The therapy, costing up to $1 million, is not yet publicly available in New Zealand.
Rachel MaherMultimedia Journalist·NZ Herald·2 Jun, 2026 05:00 PM5 mins to readMichael Walters was diagnosed with an “aggressive” form of non-Hodgkin’s lymphoma in April 2025.An Auckland man with aggressive blood cancer was weeks away from receiving cutting-edge CAR-T cell therapy through a New Zealand clinical trial when the disease spread too quickly, ruling him out of treatment.
Now, with supporters having raised more than $264,000 towards the estimated $500,000 cost of accessing the therapy
Threat to cancer ‘lifeline’: Charity fears tax change will scupper $30m lodge
New treatment gives hope to Australians with MND
For pancreatic cancer patients, an exciting drug can feel out of reach
‘I was getting ready to say goodbye’: cancer patient’s hope after smart drug success
Tamara was grappling with a cancer diagnosis. Then came the $35,000 in medical bills
Trial offers fresh hope for patients resistant to standard cancer treatments - World News
Family feels ‘powerless’ in fight over cellphone tower planned outside their home
New cancer jab returns ‘unprecedented’ results in major clinical trial
Promising bowel cancer drug gives patient ‘new lease of life’
'My granddaughter is 15 months old, and she’s not going to remember me.'
After embarking on a trial of CAR T-cell therapy, actor Sam Neill announced he is cancer-free. Researchers are enthusiastic the…
The family have been away from their Manawatū home for more than three weeks.
Although desperately ill, she is bravely sharing the lessons that matter so much.
Limited access to new treatments and slow research pipelines in Britain are pushing patients to take financial risks to fund…
Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now…
